Immunological Antineoplastic Agents

Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS.

Also Known As:

Antineoplastic Agents, Immunological; Antineoplastic MAbs; Antineoplastics, Monoclonal Antibodies; Antineoplastics, Monoclonal Antibody; MAbs, Antineoplastic; Monoclonal Antibodies, Antineoplastic; Antibodies Antineoplastics, Monoclonal; Antineoplastic Monoclonal Antibodies; Monoclonal Antibodies Antineoplastics; Monoclonal Antibody Antineoplastics

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Chemical Actions and Uses
- Pharmacologic Actions: 160
  - Therapeutic Uses: 47080
    - Antineoplastic Agents: 20689
      - Immunological Antineoplastic Agents: 2
        Immune Checkpoint Inhibitors: 22629

Experts

1.	Manegold, Christian: 1 article (09/2014)

Related Diseases

1.	Cardiotoxicity 09/25/2023 - "The European society of cardiology address that concern with antineoplastic monoclonal antibodies issuing a guideline to manage and monitor chemotherapy-induced cardiotoxicity. "
2.	Neoplasms (Cancer) 09/25/2023 - "Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: real-world evidence from a tertiary healthcare system." 09/25/2023 - "Antineoplastic monoclonal antibodies (mAbs), such as trastuzumab, bevacizumab, and pertuzumab have been the mainstay of therapy in cancer patients. "
3.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/01/2014 - "The availability of antineoplastic monoclonal antibodies, small molecules and newer cytotoxics such as pemetrexed, the EGFR-tyrosine kinase inhibitors erlotinib, gefitinib, afatinib as well as the anti-angiogenic bevacizumab and the ALK-inhibitor crizotinib has recently changes the treatment algorithm of advanced non-small cell lung cancer. "

Related Drugs and Biologics

1.	Bevacizumab (Avastin)
2.	Tyrosine Kinase Inhibitors
3.	Afatinib
4.	Crizotinib
5.	Gefitinib (Iressa)
6.	Erlotinib Hydrochloride (CP 358,774)
7.	Trastuzumab (Herceptin)
8.	Pemetrexed (MTA)
9.	pertuzumab

Related Therapies and Procedures

1.	Therapeutics
2.	Drug Therapy (Chemotherapy)